ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000259212.1	Selumetinib	Breast invasive carcinoma	0.023312805	Resistant
ENSG00000259212.1	Selumetinib	Ovarian serous cyStomach adenocarcinomaenocarcinoma	0.04621142	Resistant